Relationship Between Epicardial Adipose Tissue, Inflammation and Volume Markers in Hemodialysis and Transplant Patients

Simple item page
dc.contributor.authorÇolak H.
dc.contributor.authorKilicarslan B.
dc.contributor.authorTekce H.
dc.contributor.authorTanrisev M.
dc.contributor.authorTugmen C.
dc.contributor.authorAktas G.
dc.contributor.authorKursat S.
dc.date.accessioned2024-07-22T08:14:01Z
dc.date.available2024-07-22T08:14:01Z
dc.date.issued2015
dc.description.abstractCardiovascular (CV) diseases are still the most important cause of morbidity and mortality in both patients receiving hemodialysis (HD) treatment and individuals with renal transplantation (Rtx). Measurement of epicardial adipose tissue (EAT) thickness is an easily applied, cheap, and useful recent method predicting increased CV risk. We aimed to compare EAT changes in HD and Rtx patients and the association between EAT and inflammatory and CV volume markers in both groups. A total of 124 patients: 45 Rtx, 43 HD patients and 36 healthy controls were enrolled in the study. Laboratory parameters and inflammatory markers (interleukin-6 [IL-6] and high sensitive C-reactive protein [Hs-CRP]) were evaluated from venous blood samples after an overnight fast. EAT thickness was measured with transthoracic echocardiography. The levels of Hs-CRP, IL-6, systolic and diastolic blood pressures, left atrial (LA) diameter, left atrial index (LAI), left ventricular mass (LVM) and LVM index (LVMI) were significantly higher in the HD patients than in the other groups. EAT was positively correlated with age, body mass index (BMI), time on dialysis, serum creatinine, total cholesterol, Low density lipoprotein-cholesterol, and LVM in Rtx group and positively correlated with age, BMI, duration of dialysis, Hs-CRP, IL-6, LAI and LVMI and inversely correlated with inferior vena cava collapse index (IVC-CI) in HD group. EAT thickness of RTx patients (whose previous HD duration was similar to those in HD group) are similar to the healthy population and significantly thinner than patients on HD. Therapeutic Apheresis and Dialysis. © 2015 International Society for Apheresis.
dc.identifier.DOI-ID10.1111/1744-9987.12276
dc.identifier.issn17449979
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16469
dc.language.isoEnglish
dc.subjectAdipose Tissue
dc.subjectAdult
dc.subjectAnalysis of Variance
dc.subjectAnthropometry
dc.subjectBiological Markers
dc.subjectBody Mass Index
dc.subjectC-Reactive Protein
dc.subjectCardiovascular Diseases
dc.subjectCase-Control Studies
dc.subjectEchocardiography, Doppler
dc.subjectFemale
dc.subjectHumans
dc.subjectInflammation
dc.subjectInterleukin-6
dc.subjectKidney Failure, Chronic
dc.subjectKidney Transplantation
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPericardium
dc.subjectPrognosis
dc.subjectRenal Dialysis
dc.subjectRisk Assessment
dc.subjectSurvival Rate
dc.subjectTreatment Outcome
dc.subjectalbumin
dc.subjectC reactive protein
dc.subjectcalcium
dc.subjectcholesterol
dc.subjectcreatinine
dc.subjectglucose
dc.subjecthemoglobin
dc.subjecthigh density lipoprotein cholesterol
dc.subjectinterleukin 6
dc.subjectlow density lipoprotein cholesterol
dc.subjectparathyroid hormone
dc.subjectphosphate
dc.subjecttriacylglycerol
dc.subjectbiological marker
dc.subjectC reactive protein
dc.subjectinterleukin 6
dc.subjectadipose tissue
dc.subjectadult
dc.subjectage
dc.subjectalbumin blood level
dc.subjectArticle
dc.subjectblood analysis
dc.subjectblood pressure measurement
dc.subjectbody mass
dc.subjectbody surface
dc.subjectcalcium blood level
dc.subjectcardiovascular parameters
dc.subjectcardiovascular risk
dc.subjectcholesterol blood level
dc.subjectcontrolled study
dc.subjectcreatinine blood level
dc.subjectdiastolic blood pressure
dc.subjectdiet restriction
dc.subjectechocardiography
dc.subjectepicardial adipose tissue
dc.subjectepicardium
dc.subjectfemale
dc.subjectglucose blood level
dc.subjectgraft recipient
dc.subjectheart left atrium
dc.subjectheart left atrium index
dc.subjectheart left ventricle ejection fraction
dc.subjectheart left ventricle mass
dc.subjecthemodialysis
dc.subjecthemodialysis patient
dc.subjecthemoglobin blood level
dc.subjecthuman
dc.subjectinflammation
dc.subjectkidney transplantation
dc.subjectlaboratory test
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectparathyroid hormone blood level
dc.subjectphosphate blood level
dc.subjectpriority journal
dc.subjectsystolic blood pressure
dc.subjectthickness
dc.subjecttransthoracic echocardiography
dc.subjecttreatment duration
dc.subjecttriacylglycerol blood level
dc.subjectvenous blood
dc.subjectadipose tissue
dc.subjectadverse effects
dc.subjectanalysis of variance
dc.subjectanthropometry
dc.subjectblood
dc.subjectCardiovascular Diseases
dc.subjectcase control study
dc.subjectcomparative study
dc.subjectDoppler echocardiography
dc.subjectechography
dc.subjectinflammation
dc.subjectKidney Failure, Chronic
dc.subjectkidney transplantation
dc.subjectmetabolism
dc.subjectmiddle aged
dc.subjectmortality
dc.subjectpathophysiology
dc.subjectpericardium
dc.subjectprocedures
dc.subjectprognosis
dc.subjectrenal replacement therapy
dc.subjectrisk assessment
dc.subjectsurvival rate
dc.subjecttreatment outcome
dc.titleRelationship Between Epicardial Adipose Tissue, Inflammation and Volume Markers in Hemodialysis and Transplant Patients
dc.typeArticle

Files

Collections

Scopus Koleksiyonu